
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $442.4M | -- | -- | $1.49 | -- |
08/07/2025 | Q2 | $440.9M | -- | -- | $1.53 | -- |
05/08/2025 | Q1 | $446.8M | $466.1M | $1.59 | $1.65 | -$0.06 |
01/30/2025 | Q4 | $429.2M | $447.7M | $1.98 | $1.37 | $0.61 |
10/29/2024 | Q3 | $397.5M | $417.4M | $1.18 | $1.13 | $0.05 |
08/06/2024 | Q2 | $398.6M | $409.9M | $1.25 | $1.28 | -$0.03 |
05/02/2024 | Q1 | $391.7M | $412.7M | $0.93 | $1.16 | -$0.23 |
02/01/2024 | Q4 | $372.8M | $393.2M | $0.98 | $0.98 | -$0.00 |
10/26/2023 | Q3 | -- | -- | $0.25 | $0.80 | -$0.55 |
08/10/2023 | Q2 | -- | -- | $0.51 | $0.97 | -$0.46 |
05/02/2023 | Q1 | -- | -- | $1.00 | $0.91 | $0.09 |
02/02/2023 | Q4 | -- | -- | $0.52 | $0.88 | -$0.36 |
11/03/2022 | Q3 | -- | -- | $0.05 | $0.75 | -$0.70 |
08/11/2022 | Q2 | -- | -- | $0.18 | $1.25 | -$1.07 |
05/05/2022 | Q1 | -- | -- | $7.09 | $0.82 | $6.27 |
02/08/2022 | Q4 | -- | -- | $0.36 | $0.96 | -$0.60 |
11/03/2021 | Q3 | -- | -- | -$1.17 | $0.74 | -$1.91 |
08/19/2021 | Q2 | -- | -- | $0.18 | $0.69 | -$0.51 |
04/29/2021 | Q1 | -- | -- | $0.48 | $0.69 | -$0.21 |
02/02/2021 | Q4 | -- | -- | $0.44 | $0.67 | -$0.23 |
11/05/2020 | Q3 | -- | -- | $0.38 | $0.38 | -- |
08/18/2020 | Q2 | -- | -- | -$4.90 | $0.64 | -$5.54 |
05/05/2020 | Q1 | -- | -- | $2.83 | $0.67 | $2.16 |
02/04/2020 | Q4 | -- | -- | $0.10 | $0.55 | -$0.45 |
10/29/2019 | Q3 | -- | -- | $0.26 | $0.46 | -$0.20 |
08/22/2019 | Q2 | -- | -- | $0.86 | $0.96 | -$0.10 |
05/02/2019 | Q1 | -- | -- | $0.64 | $0.65 | -$0.01 |
02/07/2019 | Q4 | -- | -- | $0.29 | -- | -- |
11/01/2018 | Q3 | -- | -- | -$0.16 | -- | -- |
08/16/2018 | Q2 | -- | -- | $1.02 | -- | -- |
05/03/2018 | Q1 | -- | -- | $0.63 | -- | -- |
02/06/2018 | Q4 | -- | -- | -$1.33 | -- | -- |
11/01/2017 | Q3 | -- | -- | $0.20 | -- | -- |
08/17/2017 | Q2 | -- | -- | $0.67 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.62 | -- | -- |
02/02/2017 | Q4 | -- | -- | $0.23 | -- | -- |
11/01/2016 | Q3 | -- | -- | $0.39 | -- | -- |
08/18/2016 | Q2 | -- | -- | -$0.16 | -- | -- |
05/05/2016 | Q1 | -- | -- | $0.81 | -- | -- |
02/04/2016 | Q4 | -- | -- | -$0.79 | -- | -- |
10/22/2015 | Q3 | -- | -- | $0.08 | -- | -- |
Adtalem Global Education reported $466.1M worth of top line sales in its most recent quarter.
Adtalem Global Education announced earnings per share of $1.59 which represents a miss of analyst forecast a $1.65 per share.
Adtalem Global Education reported $266.2M that represents $6.96 per share over the last quarter.
Adtalem Global Education's earnings are forecast to grow from $3.39 per share to $6.54 per share next year representing an increase of 92.85%.
Adtalem Global Education's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.